MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-04-0004394
Rex Remedies Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.37 Cr
▼ 11% YoY
Net profit · FY 2025
₹19.09 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹3.39 Cr
EBITDA margin 8.6%
Authorised capital
₹1.75 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹13.75 Cr
Satisfied ₹10.19 Cr
Company age
31 yrs
Est. 1995
Directors on board
12
As per MCA filings
About Rex Remedies Limited
Data last updated:
Rex Remedies Limited is a public limited company based in Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 02 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC064991. Its GSTIN is 07AAACR1343L1ZG (Delhi). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.5 Cr. It was formerly known as Rex (U & a ) Remedies Limited. It is led by directors including Muneef Akhtar Usmani (Managing Director) and Mohd Arif (Managing Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 51/1 G T Karnal Road Industrial Area, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.37 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹19.09 Lakh (net margin 0.5%) and EBITDA of ₹3.39 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company is associated with 2 brands: Rex Remedies and Rex remedies. As per MCA filings, the company has open charges of ₹13.75 Cr and satisfied charges of ₹10.19 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it.
Rex Remedies Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0004394). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rexremedies.com.
Company Details of Rex Remedies Limited
CIN U74899DL1995PLC064991
Registration Number 064991
Incorporation Date 02 February 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-04-0004394
Name History of Rex Remedies Limited
Rex Remedies has undergone 4 name changes throughout its history. The current legal name is Rex Remedies Limited.
| Company Name | Status |
|---|---|
| Rex Remedies Limited | Current |
| Rex (U & A ) Remedies Limited | Previous |
| Rex (U And A) Remedies Limited | Previous |
| Rex (U And A) Remedies Private Limited | Previous |
CIN History of Rex Remedies Limited
Rex Remedies has one previous CIN (Corporate Identification Number): U74899DL1995PTC064991. The current CIN is U74899DL1995PLC064991, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1995PLC064991 | Current |
| U74899DL1995PTC064991 | Previous |
Key People
Muneef Akhtar Usmani Managing Director Mohd Arif Managing Director Shamshad Ahmed Managing Director Recognitions & Rankings of Rex Remedies
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressA 51/1 G T Karnal Road Industrial Area, Delhi, India – 110033
- IndustryHealthcare, Ayurvedic Products & Services
Comprehensive company report
Rex Remedies Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Rex Remedies Limited
Rex Remedies operates two associated brands: Rex Remedies and Rex remedies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sells Unani and Ayurvedic medicines through online platform in India. | rexremediesltd.com | |
| Nutraceutical company manufacturing and marketing herbal supplements | rexremedies.com |
Business Activity of Rex Remedies Limited
The main business activity of Rex Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rex Remedies Limited FY 2025 filings available
Rex Remedies Limited reported revenue of ₹39.37 Cr (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹39.37 Cr ▼ 11%
Net profit · FY 2025
₹19.09 Lakh margin 0.5%
EBITDA · FY 2025
₹3.39 Cr margin 8.6%
Compounded Annual Growth Rate (CAGR) of Rex Remedies Limited
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 1%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 16%
5 years · compounded
▲ 26%
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rex Remedies Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.39 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.09 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rex Remedies Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rex Remedies are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rex Remedies Limited
Rex Remedies has 12 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hakeem Abdul Halim | Whole-Time Director | 02 Feb 1995 | 31 Years 8 Months | Current |
| Mohd Asim Also directs: Especia Foods Private Limited, HPH Pharma Private Limited. | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
| Muneef Akhtar Usmani | Managing Director | 17 Jan 2005 | 21 Years 9 Months | Current |
| Aarifa | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
| Mohd Arif | Managing Director | 02 Feb 1995 | 31 Years 8 Months | Current |
| Mohd Anas Also directs: Rex Herbal Traders Private Limited | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
Showing 6 of 12 current directors. View all directors
Peer Comparison of Rex Remedies Limited
Rex Remedies Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sr Institute of Advanced Ayurvedic Sciences Private Limited | ₹47.61 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Haryana, India |
| Source Natural Foods and Herbal Supplements Limited Listed | ₹45 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Bangalore, Karnataka, India |
| Sunrise Remedies Private Limited | ₹40.84 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Lepro Herbals Private Limited | ₹40.25 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | New Delhi, Delhi, India |
| Brutec Pharma Private Limited | ₹39.83 Cr (FY 2025) | •••• | •••• | 301.0% | •••• | Thodupuzha, Kerala, India |
| Rex Remedies Limited this company | ₹39.37 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Delhi, India |
| Ytm India Marketing Private Limited | ₹39.24 Cr (FY 2025) | •••• | •••• | •••• | Raipur, Chhattisgarh, India | |
| Sanskar Ayush Medicare Private Limited | ₹38.99 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Haridwar, Uttarakhand, India |
| Skyline Herbals Private Limited | ₹38.76 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| A R Ayurveda Private Limited | ₹38.34 Cr (FY 2025) | •••• | •••• | 162.0% | •••• | Ahmedabad, Gujarat, India |
| Swaranimakash Life Sciences Private Limited | ₹38.23 Cr (FY 2025) | •••• | •••• | -67.0% | •••• | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Rex Remedies by revenue in the Healthcare industry (Ayurvedic Products and Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rex Remedies Limited
Rex Remedies Limited is audited by M A S A & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M A S A & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rex Remedies Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rex Remedies Limited
Open charges
₹13.75 Cr
Satisfied charges
₹10.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2024 | Axis Bank Limited | ₹9.75 Cr | Open |
| 04 Nov 2023 | Hdfc Bank Limited | ₹39.99 Lakh | Open |
| 22 Apr 2022 | Hdfc Bank Limited | ₹40.05 Lakh | Open |
| 06 Apr 2022 | Hdfc Bank Limited | ₹40.05 Lakh | Open |
| 24 Feb 2022 | Axis Bank Limited | ₹29 Lakh | Open |
Total charge records: 12 View all charges
Legal Cases of Rex Remedies Limited
Rex Remedies Limited has 4 court cases on record: 1 filed by Rex Remedies, 3 filed against it. All cases are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Total cases
4
Filed by the company
1
Filed against the company
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Govt of State of NCT of Delhi & Ors | Disposed |
| District court, South East, Delhi | Court case (TM) | Filed against the company by Dawakhana Tibiya College Muslim Universtity | Disposed |
| High Court of Delhi | Court case (LA.APP.) | Filed against the company by Union of India | Disposed |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Rex Remedies Limited
Rex Remedies Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 13 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| N.A.H. Industries | •••• | •••• | •••• |
| Alwad Seals Packaging LLP | •••• | •••• | •••• |
| Herborex Biotech Impex Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Rex Remedies Limited
Employment history and EPFO contributions of people linked to Rex Remedies.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rex Remedies Limited
Rex Remedies Limited has 30 board changes on record since 1995: 12 appointments and 18 cessations. The latest: Aarifa ceased to be Additional Director on 29 Sep 2022.
AGM
Rex Remedies Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Rex Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited amounted to Rs. 9.75 Cr with Charge ID 101013062 was registered on 17 Oct 2024.
Charges
A charge registered on 19 Dec 2018 via Charge ID 100224772 with Hdfc Bank Limited was fully satisfied on 06 May 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100836631 was registered on 04 Nov 2023.
Ceased
Aarifa ceased to be Additional Director.
Ceased
Anam Fatima ceased to be Additional Director.
Ceased
Mohammad Arif ceased to be Additional Director.
Ceased
Mohd Anas ceased to be Additional Director.
Ceased
Mohd Asif ceased to be Additional Director.
Ceased
Mohd Asim ceased to be Additional Director.
Ceased
Monis Akhtar ceased to be Additional Director.
39 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rex Remedies Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rex Remedies Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rex Remedies Limited
Rex Remedies has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACR1343L1ZG | Delhi | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rex Remedies Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rex Remedies Limited
Rex Remedies is an active public limited company based in Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 02 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC064991.
Rex Remedies reported revenue of ₹39.37 Cr for FY 2025 (down 11% YoY).
Rex Remedies has 12 current directors:
- Muneef Akhtar Usmani - Managing Director
- Mohd Arif - Managing Director
- Shamshad Ahmed - Managing Director
- Hakeem Abdul Halim - Whole-Time Director
- Mohd Asim - Director
- Aarifa - Director
- Mohd Anas - Director
- Mohd Asif - Director
- Mujeeb Akhtar - Director
- Anam Fatima - Director
- Monis Akhtar - Director
- Mohammad Arif - Director
Rex Remedies reported a net profit of ₹19.09 Lakh (net margin 0.5%) and EBITDA of ₹3.39 Cr (EBITDA margin 8.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rex Remedies is -1% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rex Remedies is 07AAACR1343L1ZG, registered in Delhi. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Rex Remedies is U74899DL1995PLC064991. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rex Remedies has 4 court cases on record: 1 filed by the company and 3 filed against it. Most are in the high courts.
Rex Remedies was incorporated on 02 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rex Remedies by revenue are Sr Institute of Advanced Ayurvedic Sciences Private Limited, Source Natural Foods and Herbal Supplements Limited, Sunrise Remedies Private Limited, Lepro Herbals Private Limited, Brutec Pharma Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services).
Aarifa ceased to be Additional Director on 29 Sep 2022. Anam Fatima ceased to be Additional Director on 29 Sep 2022. Mohammad Arif ceased to be Additional Director on 29 Sep 2022. Rex Remedies has 30 board changes on record in total.
Yes, Rex Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-DL-04-0004394).